Oxidative stress impairs multiple regulatory events to drive persistent cytokine-stimulated STAT3 phosphorylation  by Ng, Ivan H.W. et al.
Biochimica et Biophysica Acta 1843 (2014) 483–494
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r .com/ locate /bbamcrOxidative stress impairs multiple regulatory events to drive persistent
cytokine-stimulated STAT3 phosphorylationIvan H.W. Ng a,b, Yvonne Y.C. Yeap a, Lynette S.R. Ong a,1, David A. Jans b,⁎, Marie A. Bogoyevitch a,⁎⁎
a Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Victoria 3010, Australia
b Department of Biochemistry and Molecular Biology, Monash University, Victoria 3800, AustraliaAbbreviations: JAK, Janus kinase; STAT, Signal
Transcription; TC-PTP, T-cell protein tyrosine phosphatase
signalling 3; H2O2, hydrogen peroxide; LIF, leukemia inhib
MAPK, mitogen-activated protein kinase; MEF, murine e
calf serum; CLSM, confocal laser scanning microscopy; G
NES, nuclear export sequence; NLS, nuclear localisation
cence; Fc, cytoplasmic ﬂuorescence; Fn/c, the nuclear to c
error of the mean
⁎ Correspondence to: D.A. Jans, Nuclear Signallin
Biochemistry and Molecular Biology, Monash Universit
Tel.: +61 3 9901 9341; fax: +61 3 9902 9500.
⁎⁎ Correspondence to: M.A. Bogoyevitch, Department
Biology, Bio21 Molecular Science and Biotechnology Inst
30 Flemington Road, Parkville, VIC 3010, Australia. Tel.:
9348 1421.
E-mail addresses: david.jans@monash.edu (D.A. Jans),
(M.A. Bogoyevitch).
1 Present Address: Centre for Animal Biotechnology
University of Melbourne, Parkville, VIC 3010, Australia.
0167-4889/$ – see front matter © 2013 Elsevier B.V. All r
http://dx.doi.org/10.1016/j.bbamcr.2013.11.015a b s t r a c ta r t i c l e i n f oArticle history:
Received 20 August 2013
Received in revised form 31 October 2013
Accepted 19 November 2013
Available online 25 November 2013
Keywords:
STAT3
Oxidative stress
Cytokines
Nuclear transportAlthough cytokine-driven STAT3 phosphorylation and activation are often transient, persistent activation of
STAT3 is a hallmark of a range of pathologies and underpins altered transcriptional responses. As triggers in
disease frequently include combined increases in inﬂammatory cytokine and reactive oxygen species levels,
we report here how oxidative stress impacts on cytokine-driven STAT3 signal transduction events. In the
model system of murine embryonic ﬁbroblasts (MEFs), combined treatment with the interleukin-6 family cyto-
kine Leukemia Inhibitory Factor (LIF) and hydrogen peroxide (H2O2) drove persistent STAT3 phosphorylation
whereas STAT3 phosphorylation increased only transiently in response to LIF alone and was not increased by
H2O2 alone. Surprisingly, increases in transcript levels of the direct STAT3 gene target SOCS3were delayed during
the combined LIF + H2O2 treatment, leading us to probe the impact of oxidative stress on STAT3 regulatory
events. Indeed, LIF + H2O2 prolonged JAK activation, delayed STAT3 nuclear localisation, and caused
relocalisation of nuclear STAT3 phosphatase TC-PTP (TC45) to the cytoplasm. In exploring the nuclear import/
export pathways, we observed disruption of nuclear/cytoplasmic distributions of Ran and importin-α3 in cells
exposed to H2O2 and the resultant reduced nuclear trafﬁcking of classical importin-α/β-dependent protein
cargoes. CRM1-mediated nuclear export persisted despite the oxidative stress insult, with sustained STAT3
Y705 phosphorylation enhancing STAT3 nuclear residency. Our studies thus reveal for the ﬁrst time the striking
impact of oxidative stress to sustain STAT3 phosphorylation and nuclear retention following disruption of
multiple regulatory events, with signiﬁcant implications for STAT3 function.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
The proteins of Janus Kinase (JAK)/Signal Transducer and Activator
of Transcription (STAT) pathway, initially identiﬁed as important
direct signalling components linking cytokine receptor activationTransducer and Activator of
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ights reserved.to downstream transcriptional changes, have been increasingly
recognised as playing major roles in cancer and pathologies associated
with enhanced inﬂammation [1,2]. The STAT transcription factor pro-
teins are largely inactive and cytoplasmic under normal conditions,
but upon JAK-stimulated tyrosine phosphorylation, translocate to the
cell nucleus to participate directly in the expression of the STAT-
speciﬁc gene targets [3]. One member of the STAT family, STAT3, has
attracted attention as a transcription factor mediating the gene expres-
sion changes upon stimulation by the interleukin-6 family of cytokines
[4]. In this classical model of activation, STAT3 phosphorylation and
nuclear localisation are usually transient, but persistent STAT3 phos-
phorylation and activation have frequently been linked with events of
cellular injury, inﬂammation and cancer [3,5,6].
Although the mechanisms leading to persistent STAT3 activation
remain largely unclear, several regulatory events control themagnitude
and extent of STAT3 activation under control conditions. These regula-
tory events include the elevation of cytokine levels that promote recep-
tor activation with downstream activation of tyrosine kinases [7], and
conversely the involvement of negative regulators such as the tyrosine
phosphatase T-cell protein tyrosine phosphatase (TC-PTP) [8–10] and
the suppressor of cytokine signalling 3 (SOCS3) protein [11]. Notably,
SOCS3 is itself a gene target of active STAT3 and its direct regulation
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attenuating signalling by the JAK/STAT3 pathway following cytokine
activation [11].
Increased intracellular reactive oxygen species levels, leading to
oxidative stress, have also been linked to disease pathologies, often
promoting inﬂammatory processes and thus further elevating pro-
inﬂammatory cytokine levels [12,13]. Whilst recent studies have
demonstrated STAT3 activation by hydrogen peroxide (H2O2) as an
oxidative stress trigger [14–16], the impact of oxidative stress on the
magnitude and kinetics of cytokine-stimulated STAT3 phosphorylation
and activation has not been evaluated. In this study, we focus on
the consequences of oxidative stress on STAT3 activation by the
interleukin-6 family cytokine Leukemia Inhibitory Factor (LIF). Our
studies provide the ﬁrst evidence that oxidative stress prolongs
cytokine-driven STAT3 activation by deregulating multiple regulatory
events.
2. Materials and methods
2.1. Cell culture, transfection and treatments
Wild-type (WT) murine embryonic ﬁbroblasts (MEFs), STAT3−/−
MEFs, or HeLa cells were maintained in high glucose Dulbecco's modi-
ﬁed Eagle's medium (DMEM) containing L-glutamine (Gibco) supple-
mented with 10% [v/v] foetal calf serum (FCS; DKSH Australia) and
100 U/ml penicillin/streptomycin (Gibco) then changed to serum-free
media conditions 16 h before treatment with either 10 ng/ml murine
recombinant LIF (Sigma), 1 mM H2O2 (Ajax Finechem), or a combina-
tion of 10 ng/ml LIF and 1 mMH2O2 (LIF + H2O2). For selected studies,
50 μMmenadionewas used to generate superoxide in place of oxidative
stress initiated by H2O2. For protein kinase inhibitor studies, WT MEFs
were pre-treated with a Mitogen-Activated Protein Kinase (MAPK)
pathway inhibitor (20 μM JNK Inhibitor VIII [17]; 20 μMMEK inhibitor,
UO126 [18]; 20 μMp38 inhibitor, SB203580 [19]), 0.5 μMJAK inhibitor I
[20] or 10 μMSrc family kinase inhibitor SU6656 [21] for 1 h prior to LIF,
H2O2, or LIF + H2O2 treatment. Cells were pre-treated with the STAT3
pathway inhibitor STATTIC [22] (20 μM) 30 min prior to treatment
with LIF, H2O2, or LIF + H2O2. All inhibitors were from Calbiochem.
For the delivery of anti-importin-α3 or anti-importin-β1 antibodies
(Abcam) into intact cells, the Chariot peptide system was used accord-
ing to the manufacturer's instruction (Active Motif) [23,24]. Brieﬂy,
antibodies (1 μg in 100 μl PBS) were mixed with 3.5 μl Chariot peptide
solution and 100 μl distilled deionised H2O, added to 150 μL of serum-
free culture medium, and then preincubated with cells (12 well dishes)
for 4 - 12 h prior to exposure to LIF. Transient transfection studies were
carried out with the expression of myc epitope-tagged phosphatase TC-
PTP [25], or Green Fluorescent Protein (GFP)-tagged nuclear export
sequence (NES) and nuclear localisation sequence (NLS) constructs:
GFP–Rev–NES [26], GFP-T-antigen (GFP-T-ag(114–135)) [27], GFP-
pUL54(1145–1161) [28], GFP-VP3(74–121), GFP–VP3–NES mutant
[29,30] or a control GFP-only construct using Lipofectamine™ LTX
with Plus™ reagent and Opti-MEM according to the manufacturer's
instructions (Invitrogen) prior to further treatments. In control
experiments, GFP–Rev–NES cells were additionally pre-treated with
10 ng/ml Leptomycin B, a CRM1 inhibitor [31] for 60 min prior to
analysis.
2.2. Cell lysate preparation and immunoblot analysis
Following treatment, cell lysates were prepared using RIPA buffer
(50 mMTris–HCl, pH 7.3, 150 mMNaCl, 0.1 mMEDTA, 1% [v/v] sodium
deoxycholate, 1% [v/v] Triton X-100, 0.2% [w/v] NaF and 100 μM
Na3VO4) supplemented with complete protease inhibitor mix (Roche
Diagnostic). Protein samples, diluted with 3× protein sample buffer,
were resolved by SDS-PAGE (10% [v/v] polyacrylamide gels) and
the separated proteins were transferred onto PVDF membranes(Amersham Life Science). Proteins of interest were blotted using the
following primary antibodies: anti-STAT3 N-terminus (BD Bioscience),
anti-phospho-Y705 STAT3 or phospho-S727 STAT3 (Cell Signaling
Technology), anti-TC-PTP (R & D systems), anti-α-tubulin (Sigma) and
anti-c-Myc epitope (Santa Cruz Biotechnology). After incubation with
horseradish peroxidase-linked secondary antibody (Thermo Scientiﬁc),
immunoreactive proteins were visualized using an enhanced chemilu-
minescence detection system (Thermo Scientiﬁc) and quantitation
carried out using ImageJ 1.38 public domain software (National
Institutes of Health, USA).2.3. Immunoﬂuorescence, confocal laser scanning microscopy and image
analysis
Samples were prepared and analysed as described previously
[32]. Brieﬂy, treated cells on coverslips were washed with cold
phosphate-buffered saline (PBS) before ﬁxation using 4% [w/v] para-
formaldehyde (15 min, 37 °C) and permeabilisation in 0.2% [v/v]
Triton X-100/PBS (15 min, room temperature). Non-speciﬁc binding
was blocked by incubation in 1% [w/v] bovine serum albumin/PBS
(30 min, room temperature), then coverslips incubated with prima-
ry antibodies [STAT3 (C-20) (Santa Cruz), Ran (BD Bioscience),
importin-α3/KPNA4 or importin-β1/NTF97 (Abcam), 1:200 dilution
in sterile ﬁltered 1% [w/v] bovine serum albumin/PBS] then washed
with PBS before incubation with Cy2/Cy3- (Millipore) or Alex488-
coupled (Invitrogen) secondary antibodies. Nuclei were visualized
using DAPI (Sigma, 1:15000 in PBS). Coverslips were mounted
(Biomeda Gel Mount, ProSciTech) onto glass slides and confocal
laser scanning microscopy was performed using a Leica TCS SP2
imaging system with a 100 × 1.35 NA objective. Quantitation of
relative ﬂuorescence intensities in digitised confocal images was
carried out by measuring ﬂuorescence in an area of the nucleus
and cytoplasm of cells in 10 different ﬁelds (ImageJ 1.38 public
domain software) from 3 independent experiments (n = 3). The
values for the nuclear (Fn) and cytoplasmic (Fc) ﬂuorescence,
subsequent to subtraction of background ﬂuorescence, enabled the
speciﬁc nuclear to cytoplasmic ratio (Fn/c) to be calculated [32].2.4. RNA preparation and quantitative real-time PCR
Samples were prepared and analysed as described previously [32].
Brieﬂy, total RNA was extracted from MEFs using the Purelink RNA
mini-kit (Invitrogen) and reverse-transcribed to cDNA using the RT
High Capacity kit (Applied Biosystems) according to the manufacturer's
protocols. Quantitative real-time TaqMan® PCR to determine the
regulation of SOCS3 transcript levels was performed using 50 ng cDNA
in a 20 μl reaction containing TaqMan® Gene Expression Master
Mix and speciﬁc TaqMan® Gene Expression Assay (AssayID: SOCS3,
Mm00545913_s1; Applied Biosystems). Ampliﬁcation of cDNA was car-
ried out in a 48-well StepOne real-time PCR system (Applied Biosystems)
using the following PCR conditions: 2 min at 50 °C and 10 min at 95 °C,
followed by 40 cycles of 15 s at 95 °C and 1 min at 60 °C. The data was
normalised to GAPDH (AssayID: Mm99999915_g1) in the respective
samples and data quantitation was carried out using the 2−ΔΔCT method
and expressed relative to the control sample. RNA isolation and expres-
sion analysis were performed on 3 independent occasions.2.5. Statistical analysis
Statistical analysis was carried out using Graphpad Prism 5 software
(Windows version 5.00, GraphPad Software) and the unpaired student
T-testwas used to compare data from control cells versus treated cells at
each corresponding time point.
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3.1. Treatmentwith LIF andH2O2 in combination results in sustained STAT3
Y705 and S727 phosphorylation and delayed expression of SOCS3
To test the impact of oxidative stress on STAT3 signalling, we
exposed MEFs to 1 mM H2O2 or 10 ng/ml Leukemia Inhibitory Factor
(LIF), as well as a combination of both stimuli (LIF + H2O2), for up to
2 h. STAT3 activation was analysed by immunoblotting for phosphory-
lation of STAT3 at Y705 (pY705 STAT3, required for dimerization and
nuclear translocation [3]), and S727 (pS727 STAT3, linked to increased
STAT3 transactivation [33]). Consistent with LIF-stimulated STAT3 acti-
vation, we observed rapid and transient increases in both pY705 and
pS727 STAT3 following exposure to LIF (Fig. 1A). Exposure to H2O2 for
up to 2 h stimulated a detectable increase in pS727 STAT3 without an
accompanying increase in pY705 STAT3, but the combined treatment
of LIF + H2O2 resulted in increased and sustained pY705 STAT3 togeth-
er with delayed pS727 STAT3 (Fig. 1A). Densitometric analysis and
statistical evaluation of the quantitative data from three independent
experiments conﬁrmed these observations of sustained pY705 STAT3
and delayed pS727 STAT3 following LIF + H2O2 co-exposure (Fig. 1B).
To ensure this sustained STAT3 Y705 phosphorylation was not
reliant on the MEF cell background, we also exposed HeLa cells to co-
treatment with oncostatin M + H2O2 and demonstrated that the pres-
ence of H2O2 could sustain the STAT3 phosphorylation in response to
the cytokine oncostatin M (Fig. 1C, and quantitative data in Supp.
Fig. 1A). Similarly, to ensure that the responses were not speciﬁc for
H2O2, we also exposed MEFs to the co-treatment of LIF + menadione,
a superoxide generator, and again demonstrated the sustained STAT3
phosphorylation (Fig. 1D, and quantitative data in Supp. Fig. 1B),
emphasizing that different initiators of oxidative stress can promote
prolonged STAT3 activation in different cell types in the presence of
IL6 family cytokines. Furthermore, replacing LIF + H2O2-containing
medium with control serum-free medium could reverse the changes,
implying that the observed increases in STAT3 phosphorylation areA 2O2LIF H LIF + H2O2
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Fig. 1.Oxidative stress drives reversible persistent cytokine-stimulated STAT3 phosphorylation.
indicated. (A) Lysates were subjected to immunoblot analysis for activated STAT3 (pY705 or pS
noblots for STAT3, STAT3 pY705 and STAT3 pS727 (n = 3)wasperformedusing ImageJ softwar
Data represent themean ± SEM. Asterisks denote statistically signiﬁcant differences between c
cells were treated with 10 ng/ml oncostatin M (OSM), 1 mM H2O2 or OSM + H2O2 for the tim
LIF + MEN. Lysates were subjected to immunoblot analysis as per (B). (E) MEFs were treated
(0–60 min as indicated). Lysates were subjected to immunoblot analysis as per (B).not the result of irreversible damage to the cell regulatory system
during oxidative stress (Fig. 1E, and quantitative data in Supp. Fig. 1C).
To determine the impact of oxidative stress on STAT3 transcriptional
activity, we used RT-PCR to evaluate the expression of SOCS3, a well-
known STAT3 direct target gene [11]. In the presence of LIF alone, a
robust increase in SOCS3 was observed at 15 min (Fig. 2), correspond-
ing with the peak in STAT3 pY705 and pS727 (Fig. 1). H2O2 treatment
alone did not induce SOCS3 expression, but LIF + H2O2 treatment
resulted in a delayed increase in SOCS3 expression. We conﬁrmed
STAT3 inhibition by STATTIC (20 μM) [22] (Supp. Fig. 2), and demon-
strated the requirement for STAT3 in SOCS3 expression by showing
that pre-treatment with STATTIC blocked SOCS3 induction in
LIF + H2O2-treatedWTMEFs, and that therewas a lack of SOCS3 induc-
tion in response to LIF/H2O2/LIF + H2O2 in STAT3−/− MEFs (Fig. 2).
Taken together, these results indicate a delayed STAT3-dependent reg-
ulation of SOCS3 expression following the combined cytokine and
oxidative stress treatment despite persistent STAT3 phosphorylation.
3.2. JAKs and Src family kinases, but not MAPKs, contribute to STAT3
phosphorylation during combined LIF + H2O2 exposure
We next evaluated whether upstream regulators of STAT3 phos-
phorylation could be responsible for the altered STAT3 phosphorylation
and transcriptional activation following exposure to LIF + H2O2. There
were no changes in the levels of JAK1 or 2, or in the kinetics of
phosphorylation of JAK1 (pY1022) or JAK2 (pY1007) in the combined
presence of LIF + H2O2 detected by immunoblotting (Supp. Fig. 3).
The pan JAK inhibitor I prevented pY705 phosphorylation in response
to LIF or LIF + H2O2 treatment (Fig. 3A, and quantitative data in Supp.
Fig. 4A), consistent with the central role for the JAKs as the key media-
tors of STAT3 Y705 phosphorylation status. Since oxidative stress can
also upregulate Src family kinase activity [34], we tested whether the
Src family kinase inhibitor SU6656 could alter STAT3 phosphorylation.
Markedly reduced levels of STAT3 Y705 phosphorylation upon
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ment of Src family kinases in upstream regulatory events leading to
STAT3 Y705 phosphorylation induced by LIF in the absence or presence
of H2O2.
As LIF + H2O2 treatment also increased pS727 STAT3 levels
(Fig. 1A), we evaluated the mitogen-activated protein kinases
(MAPKs) that have been implicated as direct regulators of STAT3
pS727 [33]. We examined the effects of inhibitors of the different
MAPK pathways (JNK Inhibitor VIII directed at the JNKs, SB203580 di-
rected at p38 MAPK, and UO126 directed at MEK1/2 within the
ERK pathway). None of the inhibitors altered the LIF-, H2O2- or
LIF + H2O2-stimulated increases in pY705 or pS727 STAT3, althoughA
B
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Fig. 3. JAK and Src family tyrosine kinases contribute to persistent STAT3 Y705 phosphor-
ylation driven by cytokine and oxidative stress stimulation. MEFs were pre-treated (1 h)
with DMSO as a control, (A) 0.5 μM JAK Inhibitor I, or (B) 10 μM SU6656 before exposure
to 10 ng/ml LIF, 1 mMH2O2 or LIF + H2O2 for the times indicated. Lysateswere subjected
to immunoblot analysis as per the legend to Fig. 1.clearly being active in inhibiting phosphorylation of their respective
speciﬁc pathway components (Fig. 4A, B and C, and quantitative data
in Supp. Fig. 5A, B and C, respectively). Thus, proline-directed kinases
other than these MAPKs are likely responsible for mediating the in-
creases in pS727 STAT3observed in response to LIF, H2O2 or LIF + H2O2.3.3. H2O2 induces delayed LIF-dependent STAT3 nuclear translocation and
mislocalisation of STAT3 phosphatase TC-PTP (TC45) to the cytoplasm
As STAT3 phosphorylation is required for cytokine-stimulated STAT3
nuclear localisation [3], we evaluated STAT3 localisation, under condi-
tions of combined cytokine stimulation and oxidative stress, using
both total STAT3 and STAT3 pY705 antibodies. In contrast to H2O2
alone that had no effect, LIF induced a rapid increase in nuclear and
phosphorylated STAT3 in the ﬁrst 15 min of exposure followed by a
decrease in nuclear levels (Fig. 5). Combined LIF + H2O2 treatment
appeared to delay nuclear STAT3 localisation but resulted in prolonged
nuclear STAT3 levels over the 2 h treatment that correlated with the in-
creasing nuclear pY705 staining over the 2 h treatment (Fig. 5A and C).
Thiswas conﬁrmed by quantitative analysis (Fig. 5B and D). Clearly, LIF-
induced nuclear translocation kinetics are altered in the presence of
H2O2.
In addition to upregulated tyrosine kinase activity, sustained STAT3
phosphorylation can also result from reduced STAT3 phosphatase activ-
ity [35,36], with oxidative stress known to impact on tyrosine phospha-
tases in particular [37]. Since the nuclear phosphatase T-cell protein
tyrosine phosphatase (TC-PTP) can dephosphorylate nuclear pY705-
STAT3 [9,35,38,39], we examined TC-PTP under conditions of LIF, H2O2
or LIF + H2O2 exposure. Immunoblot analysis revealed a signiﬁcant
(up to 60%) decrease in the total levels of detectable endogenous TC-
PTP following exposure of MEFs to H2O2 or LIF + H2O2 (Fig. 6A, and
quantitative data in Fig. 6B); loss could be reduced by the inclusion of
the proteasomal inhibitor MG132 (Fig. 6C, and quantitative data in
Fig. 6D), thus implying proteasomal degradation of TC-PTP under the
conditions of oxidative stress.
The nuclear/cytoplasmic distribution of TC-PTP under conditions of
oxidative stress, a factor of key importance in providing access to its
nuclear or cytoplasmic substrates [25], was also examined by transient-
ly transfecting MEFs to express myc epitope tagged-TC-PTP and
performing immunostaining in the absence or presence of cytokine
and H2O2. Our analysis conﬁrmed the exclusive nuclear localisation of
myc-TC-PTP in either the absence or presence of LIF alone, but revealed
signiﬁcant (p ≤ 0.001) relocalisation of myc-TC-PTP from the nucleus
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3.4. Oxidative stress disrupts nuclear transport protein distributions and
functions
With our results highlighting altered cytoplasmic/nuclear distri-
bution of both STAT3 and TC-PTP, we extended our analyses toSTAT3
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Ran in response to treatment with LIF, H2O2 or LIF + H2O2. Whilst
importin-β1 localisation remained predominantly cytoplasmic/
nuclear envelope-localised throughout 60 min of each treatment
(Fig. 7A, and quantitative data in Fig. 7B), both importin-α3 and
Ran showed altered localisation even after 15 min of H2O2 treat-
ment, with importin-α3 accumulating in the nucleus (Fig. 7C, and
quantitative data in Fig. 7D) and Ran mislocalising to the cytoplasm
in the absence or presence of LIF (Fig. 7E, and quantitative data in
Fig. 7F). Indeed, the aberrant localisation of both importin-α3 andRan proteins could be observed within 5 min of H2O2 treatment
(Ivan Ng, unpublished data). Quantitative image analysis to deter-
mine Fn/c values conﬁrmed these results, with importin-α3 and
Ran showing signiﬁcantly (p b 0.001) altered Fn/c values in the
presence of H2O2 regardless of LIF stimulation (Fig. 7D and F). Com-
parable nuclear and cytoplasmic mislocalisation of importin-α3 and
Ran respectively was observed following exposure to 50 μM mena-
dione to induce oxidative stress (Supp. Fig. 7). Thus, oxidative stress
has clear effects on localisation of key components of the cellular
nuclear transport machinery.
nim06nim0
IMP- 1
15 min
LIF
H2O2
LIF + 
H2O2
IMP- 3
nim06nim0 15 min
LIF
H2O2
LIF + 
H2O2
Ran
nim06nim0 15 min
LIF
H2O2
LIF + 
H2O2
A
C
E
B
D
F
15 min
60 min
Im
po
rti
n-
1 
F n
/c
Co
nt
ro
l LIF H2O2 LIF + 
H2O2
0.3
0.2
0.1
0
R
an
 F
n
/c
Co
nt
ro
l
3
2
1
0
15 min
60 min
LIF H2O2 LIF + 
H2O2
∗∗∗
∗∗∗
Im
po
rti
n-
3 
F n
/c
Co
n
tro
l LIF H2O2 LIF + 
H2O2
3
2
1
0
15 min
60 min
∗∗∗
∗∗∗
n = 
53
n = 
58
n = 
63
n = 
45 n = 
66
n = 
45
n = 
67
n = 
53 n = 
55
n = 
66
n = 
60
n = 
45
n = 
58 n = 
55
n = 
53
n = 
51 n = 
56
n = 
43
n = 
56 n = 48
n = 
51
α
α
β
α
Fig. 7. Oxidative stress disrupts importin-α3 and Ran but not importin-β1 subcellular localisation. MEFs were treated with agents as per the legend to Fig. 1. Confocal laser scanning mi-
croscopy analysis was performed on immunostained cells using speciﬁc primary antibodies for (A & B) importin-β1 (IMP-β1), (C & D) importin-α3 (IMP-α3) or (E & F) Ran, followed by
the appropriate ﬂuorescently labelled secondary antibodies. Bars represent 10 μm. (B, D & F) Quantitative results for importin-β1, importin-α3 and Ran localisation using ImageJ software
to determine the Fn/c as per the legend to Fig. 5B; data represent themean ± SEM. Asterisks denote statistically signiﬁcant differences between treated and control cells as per the legend to
Fig. 1B.
489I.H.W. Ng et al. / Biochimica et Biophysica Acta 1843 (2014) 483–494To investigate further the extent to which the effect of H2O2 on LIF-
dependent STAT3 nuclear translocation might relate to the mis-
localisation of key components of STAT3's nuclear transport pathway,
we tested the effect of pre-treatment with H2O2 on STAT3 trafﬁcking.Strikingly, even though H2O2 pre-treatment for 15 or 60 min caused re-
distribution of Ran to the cytoplasm and importin-α3 to the nucleus to
similar extents, LIF-induced translocation of STAT3 from the cytoplasm
to the nucleus was not abrogated (Fig. 8A, and quantitative data in
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491I.H.W. Ng et al. / Biochimica et Biophysica Acta 1843 (2014) 483–494Fig. 8B). Further, H2O2 pre-treatment for 15 min resulted in higher
STAT3 nuclear accumulation 60 min after LIF addition compared to
cells not pre-treated with H2O2. Experiments were also performed
where H2O2 was added 15 min post-LIF treatment, conditions which
again mislocalised Ran and importin-α3 to the cytoplasm and nucleus
respectively (Fig. 8C, and quantitative data in Fig. 8D); in this case,
H2O2 treatment post-LIF addition prolonged the high levels of STAT3
in the nucleus (Fig. 8C and D; Fn/c ~ 4–5) up to 60 min. Evaluation of
pY705 STAT3 levels under these different conditions conﬁrmed
sustained phosphorylation of STAT3 (Fig. 9) as the likely basis of the
prolonged nuclear retention of STAT3.
To conﬁrm that oxidative stress-induced alterations in the nuclear
transport machinery impacted on cellular nuclear transport generally,
we examined the effect of H2O2 on the subcellular localisation of the
NLS-containing GFP-tagged nuclear import cargoes GFP-conjugated
SV40 large T-antigen (GFP-T-ag) and human cytomegalovirus polymer-
ase UL54 (GFP-pUL54), representative of importin-α/β1-dependent
transport [27,28], and the importin-β1-speciﬁc nuclear import cargo
GFP-VP3 (chicken anaemia virus viral protein 3) [29,30]; since VP3
also contains a CRM1 (exportin 1)-recognised nuclear export signal
(NES), we used a NES-inactivated mutant derivative, whilst a VP3 con-
struct containing an intact NES, in addition to the NLS/NES-containingFig. 8. Oxidative stress impacts on LIF-dependent STAT3 nuclear accumulation either pre- or p
times prior to exposure to 10 ng/ml LIF for 15 or 60 min in the continued presence of H2O2. (
using speciﬁc antibodies for STAT3, Ran and importin-α3 (IMP-α3) as per the legends to Figs. 5
software to determine the Fn/c as per the legend to Fig. 5B; data represent themean ± SEM. Ast
(**, p ≤ 0.01; ***, p ≤ 0.001). (C & D) MEFs were pre-treated with 10 ng/ml LIF for 15 min pri
(C) Confocal laser scanning microscopic analysis was performed on immunostained cells as
using ImageJ software to determine the Fn/c as per the legend to Fig. 5B; data represent the meHIV-1 Rev protein [26], were also analysed. All of the nuclear import
cargoes showed signiﬁcantly reduced (p ≤ 0.001) nuclear accumula-
tion, in contrast to GFP alonewhich showedno effect of H2O2 treatment,
implying no impact of oxidative stress on passive diffusion through the
nuclear pore (Fig. 10A, and quantitative data in Fig. 10B).We conﬁrmed
that CRM1-mediated nuclear export of GFP-Rev-NES was sensitive to
the CRM1 inhibitor leptomycin B (Supp. Fig. 8). GFP-Rev-NES was unaf-
fected in the presence of H2O2 (Fig. 10), implying that nuclear export
was still functional and this was further conﬁrmed through the evalua-
tion of the export of endogenous RanBP1 that continued in the presence
of H2O2 (Supp. Fig. 9). Thus, the main impact on nucleocytoplasmic
transport of Ran mislocalisation due to H2O2 treatment appears to be
on importin-dependent nuclear import rather than nuclear export.
4. Discussion
Cytokine-stimulated STAT3 phosphorylation has been typically
shown to be both rapid and transient under normal, non-stressed con-
ditions. Detailed studies both in vitro and in vivo have revealed a coor-
dinated negative regulatory network contributing to the kinetics of this
activation, highlighting the importance of proteins such as TC-PTP [9]
and SOCS3 [11]. A persistent activation of JAK/STAT3 signalling hasost-cytokine addition. (A & B) MEFs were pre-treated with 1 mM H2O2 for the indicated
A) Confocal laser scanning microscopy analysis was performed on cells immunostained
A and 7. (B) Quantitative results for STAT3, Ran and importin-α3 localisation using ImageJ
erisks denote statistically signiﬁcant differences for cells analysed under control conditions
or to exposure to 1 mM H2O2 (15–45 min as indicated) in the continued presence of LIF.
per (A & B) above. (D) Quantitative results for STAT3, Ran and importin-α3 localisation
an ± SEM. (A & C) Bars represent 10 μm.
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ing of the molecular drivers of this aberrant regulation is urgently
required. Oxidative stress induced by H2O2, superoxide or ultraviolet
radiation can activate STAT3 in the absence of cytokine stimulation
[15,16,44,45]. Our studies here have addressed for the ﬁrst time the
impact of oxidative stress on cytokine-driven STAT3 signalling events.Fig. 11. Schematic diagram of the impact of oxidative stress on cytokine-driven STAT3 activati
signal transduction pathway in which negative regulators such as TC-PTP and SOCS3 limit th
the STAT3 pathway are altered: TC-PTP ismislocalised and its levels are downregulated, Ran an
phosphorylation and nuclear localisation of STAT3.As summarized in Fig. 11A, the key cytokine-stimulated events regulat-
ing STAT3 have been well described. However, as summarized in
Fig. 11B, we have shown the simultaneous exposure to H2O2 and the
cytokine LIF drives a striking and persistent phosphorylation of STAT3,
but that the activation of SOCS3 expression as a direct target gene of
STAT3 is slowed and the nuclear import machinery exempliﬁed byon. (A) Under normal (non-stressed) conditions, the cytokine LIF activates the JAK-STAT3
e duration of signalling events. (B) During oxidative stress, multiple regulatory events of
d importin-α3 distributions are altered. The result of these changes is seen in the sustained
493I.H.W. Ng et al. / Biochimica et Biophysica Acta 1843 (2014) 483–494cytosolic/nuclear distributions of importin-α3 and Ran is disrupted. In
combination, these changes slow the nuclear accumulation of STAT3
but also allow for its persistent nuclear retention.
Studies on the impact of stress on nuclear transport events have
previously deﬁned changes in importin localisation and the Ran
gradient [46–49]. Importantly, these disruptions noted under the
conditions of ultraviolet radiation, oxidative stress, and heat shock
are predicted to have a profound inﬂuence on the nuclear transport
of the wide range of nuclear-destined cargoes dependent on
these importin proteins. Previous studies have shown that STAT3
nuclear import relies on importin-α3 that interacts with STAT3's
NLS (150RKRQDLEQKMK162 within the coiled-coil domain [42]),
importin-β1, and a Ran gradient [41]. Here, we demonstrate the
striking redistribution of importin-α3 and Ran, as well as a
relocalisation of the phosphatase TC-PTP and a delay in the nuclear
entry of STAT3 during oxidative stress. Paradoxically, a cytokine-
driven nuclear entry of STAT3 remains possible despite the
importin-α3 and Ran disruptions and can be observed even when
the oxidative stress insult precedes cytokine stimulation.
With such disruptions to the classical nuclear import pathway, the
possibility for a non-Ran dependent nuclear transport mechanism for
critical proteins such as the STAT3 transcription factor requires careful
consideration. Activated STAT3 can accumulate in the nucleus through
non-canonical nuclear import pathways [50–53]. Indeed, an import
pathway requiring receptor-mediated endocytosis trafﬁcking has been
proposed as critical for signalling by cytokines that are weak STAT3
activators. Thus, the formation of signalling endosomes protects and
prolongs the activation of signalling proteins, but this is not required
for the potent activation of STAT3 by interleukin-6 family cytokines
[51–53]. Alternative stress-evoked mechanisms have been proposed
as critical for the nuclear transport of Hsp70 during heat stress
[54,55]; whether these may apply to other types of stress, including
oxidative stress, remains to be determined. This will be particularly im-
portant in understanding how critical mediators of stress responses
such as signalling proteins and transcription factors can continue to
enter the nucleus of the stressed cell. Indeed, a number of protein
kinases are reported to show enhanced nuclear retention in response
to stress [56], suggesting their nuclear entry will also require mecha-
nisms that are not reliant on the classical Ran-dependent importin
pathways.
The sustained nuclear retention of cytokine-activated STAT3 we ob-
served during oxidative stress also challenges our understanding of the
STAT3 export pathway. Importantly, the dephosphorylation of STAT3
Y705 is required for its nuclear export by CRM1 [57]. The expression
and localisation of TC-PTP are critical regulators of nuclear STAT3
Y705 phosphorylation [9,35,38,39]. The mislocalisation of TC-PTP has
been reported previously for cells subjected to hyperosmotic stress
[25]. In that study, as the hyperosmotic stress-induced nuclear exit of
TC-PTP was not inhibited by leptomycin B, the nuclear export of TC-
PTP appeared to be independent of the exportin CRM1 [25]. Similarly,
we observed TC-PTP mislocalisation during oxidative stress by tracking
the localisation of myc-tagged TC-PTP. Although further studies will
require more extensive evaluation of factors impacting on the
localisation of the endogenous TC-PTP under conditions of oxidative
stress (i.e., rather than following exogenously expressed myc-tagged
TC-PTP protein, anti-TC-PTP antibodies suitable for use in immunostain-
ing protocols will be needed), our observed loss of the endogenous TC-
PTP protein during oxidative stress, adds to the key stress-stimulated
events impeding STAT3 dephosphorylation in the nucleus (see
Fig. 11B). Our analysis of the nuclear export of the CRM1-dependent
cargoes GFP-Rev-NES or RanBP1 clearly demonstrated that impairment
of the Ran gradient was not sufﬁcient to affect their predominantly
cytoplasmic localisations. Thus, the prolonged STAT3 phosphorylation
would appear to be the key to the enhanced nuclear localisation of
STAT3 under the conditions of combined cytokine and oxidative stress
stimulation.The signiﬁcance of our ﬁndings is reinforced by the intense interest
directed towards STAT3 as part of altered signalling events in a range
of pathologies, and a concerted effort to deﬁne signalling nodes
for therapeutic targeting [58,59]. Some studies have suggested that
oxidative stress per se can induce STAT3 Y705 phosphorylation as a
downstream consequence of growth factor activation [34,60]. Our
results reveal a requirement for JAKs and Src family kinases in the acti-
vation of STAT3 driven by oxidative stress and cytokine stimulation and
suggest that targeting these kinases will contribute to alleviating detri-
mental consequences of STAT3 activation noted in disease. Taken
together, the results presented in our study reveal that the disruption
of several regulatory mechanisms leads to a delayed nuclear accumula-
tion and transcriptional response by STAT3.
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